24 June 2020 in The Kaohsiung Journal of Medical Sciences
Asthma is an inflammatory syndrome characterized by airway hyperresponsiveness, bronchial inflammation, and airway remodeling. The hypertrophy and hyperplasia of airway smooth muscle cells (ASMCs) are hallmarks of bronchial remodeling in asthma. In this study, the regulatory effects of microRNA‐620 (miR‐620) on ASMC proliferation and apoptosis in response to transforming growth factor β1 (TGF‐β1) stimulation was investigated. The expression of miR‐620 was significantly upregulated in TGF‐β1‐treated ASMCs compared with vehicle‐treated cells. Downregulation of miR‐620 suppressed the proliferation and increased apoptosis in TGF‐β1‐stimulated ASMCs. Phosphatase and tensin homolog (PTEN) was predicted and confirmed as a downstream target of miR‐620. PTEN was upregulated in miR‐620‐inhibitor transfected ASMCs, but decreased in cells delivered with miR‐620 mimics. Moreover, knocking down miR‐620 alone efficiently reduced the phosphorylation of protein kinase B (AKT), decreased TGF‐β1‐induced proliferation and promoted apoptosis in ASMCs, whereas downregulation of PTEN in miR‐620 inhibitor‐transfected cells restored the activation of AKT, increased TGF‐β1‐triggered proliferation, and partially inhibited ASMC apoptosis. Taken together, the present study provided evidence that miR‐620 increased TGF‐β1‐mediated proliferation and suppressed apoptosis in ASMCs via the regulation of PTEN and AKT expression. These findings suggest that miR‐620/PTEN/AKT axis may be considered as a therapeutic target for asthma treatment.
12 October 2017 in Biotechnology & Biotechnological Equipment
The effect of timosaponin AIII (TSA-III) on human leukaemia HL-60 cells and the underlying mechanism of action were explored in this study. HL-60 cells were treated with different concentrations of TSA-III, and then the survival rate and apoptosis rate of the cells, expression of apoptosis-related genes, activation of caspase-3, cell distribution in the cell cycle phases, and expression level of the related signal pathway proteins were detected. The results showed that TSA-III could dose- and time-dependently inhibit the proliferation of HL-60 cells. TSA-III could also increase the apoptosis rate of HL-60 cells, the level of Bax and Bak mRNA and the activation rate of caspase-3, and decrease the level of Bcl-2 mRNA. At the same time, the proportion of HL-60 cells treated with TSA-III in G0/G1 phase increased, whereas the proportion of the cells in S phase decreased. In addition, TSA-III could elevate the expression of PTEN protein, and reduce the expression of p-AKT, β-catenin, Cyclin D1 and C-myc proteins. These results indicate that TSA-III should have a cytotoxic effect on HL-60 cells, mainly showing its inhibition on the proliferation, inducing the apoptosis and cell cycle arrest, and the mechanism may be related to its inhibition of PI3K/AKT and Wnt/β-catenin pathways.